Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4400 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
British Pharmacopoeia logo
Duloxetine hydrochloride
REF: 47-1289
CAS: 136434-34-9
99.9%242.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Donepezil impurity standard
REF: 47-1292
CAS:
- - -211.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Duloxetine impurity standard
REF: 47-1290
CAS:
- - -211.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Chlorhexidine impurity standard
REF: 47-1299
CAS:
- - -211.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Donepezil hydrochloride
REF: 47-1291
CAS: 884740-09-4
94.0%242.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Norgestrel impurity H CRS
REF: 41-Y0002438
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Mefloquine for system suitability CRS
REF: 41-Y0002421
CAS: 51773-92-3
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Lercanidipine hydrochloride CRS
REF: 41-Y0002424
CAS: 132866-11-6
- - -455.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Norgestrel for system suitability CRS
REF: 41-Y0002426
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Morphine hydrochloride trihydrate - Reference spectrum
REF: 41-Y0002443
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Etonogestrel impurity mixture CRS
REF: 41-Y0002416
CAS: 75-05-8
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Ciprofibrate for system suitability B CRS
REF: 41-Y0002450
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Polysorbate 80 CRS
REF: 41-Y0002469
CAS: 9005-65-6
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Polysorbate 20 CRS
REF: 41-Y0002464
CAS: 9005-64-5
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Polysorbate 60 CRS
REF: 41-Y0002468
CAS: 9005-67-8
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Erlotinib hydrochloride CRS
REF: 41-Y0002444
CAS: 183321-74-6
- - -228.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Polysorbate 40 CRS
REF: 41-Y0002467
CAS: 9005-66-7
- - -115.00 €Wed 08 Jan 25
EDQM - European Pharmacopoeia logo
Erlotinib impurity mixture CRS
REF: 41-Y0002445
- - -115.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Clopidogrel Hydrogen Sulfate
REF: 47-1305
CAS: 120202-66-6
99.4%242.00 €Wed 08 Jan 25
British Pharmacopoeia logo
Brimonidine Tartrate
REF: 47-1307
CAS: 70359-46-5
99.4%242.00 €Wed 08 Jan 25
discount label

Duloxetine hydrochloride


Ref: 47-1289

100mg242.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 47-1292

10mg211.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 47-1290

10mg211.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 47-1299

10mg211.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Donepezil hydrochloride


Ref: 47-1291

100mg242.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002438

0.003mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002421

15mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002424

90mg455.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002426

10mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002443

1u115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002416

100µl115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002450

2.03mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002469

100mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002464

100mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002468

100mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002444

150mg228.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002467

100mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Ref: 41-Y0002445

0.002mg115.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Clopidogrel Hydrogen Sulfate


Ref: 47-1305

100mg242.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
discount label

Brimonidine Tartrate


Ref: 47-1307

100mg242.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".